Target intelligence / Profile preview

Fungal antigens

Molecular classification
Polysaccharide, Glycoprotein, Protein, Lipid
01

Overview

Fungal antigens are a heterogeneous group of molecules, including polysaccharides, proteins, and lipids, that constitute the structural and functional components of fungi. These antigens, such as beta-glucans, mannans, and chitin, are primarily located in the fungal cell wall and play vital roles in maintaining cellular integrity and mediating interactions with the host environment (Erwig & Gow, 2016). In the context of infectious diseases, they are the primary targets for the host's innate and adaptive immune responses, often triggering inflammatory cascades (Netea et al., 2015). Therapeutically, fungal antigens are exploited as targets for antifungal vaccines and monoclonal antibodies, which aim to enhance pathogen clearance or neutralize virulence factors (Edwards, 2012). Additionally, specific antigens like galactomannan and cryptococcal capsular polysaccharide serve as essential diagnostic biomarkers for identifying invasive mycoses in clinical settings (Odabasi et al., 2004). Drugs such as echinocandins work by inhibiting the synthesis of these antigenic components, specifically 1,3-beta-D-glucan, thereby disrupting the fungal cell wall (Perfect, 2017). Despite their utility, the high degree of variability in antigen expression across different fungal species and life stages poses a significant challenge for the development of universal antifungal therapies.

Other names
Mycological antigensFungal immunogensFungal cell wall componentsFungal pathogen-associated molecular patterns (PAMPs)
02

Mechanism of action

Inhibition of cell wall component synthesis, direct antibody-mediated neutralization, and induction of active immunity through vaccination (Perfect, 2017; Edwards, 2012).

03

Biological functions

Cell wall organizationAdhesion to host cellsImmune evasionPathogenesisStructural integrity
04

Disease associations

Invasive candidiasisAspergillosisCryptococcosisMycosisAllergic bronchopulmonary aspergillosis (ABPA)
05

Safety considerations

Infusion-related reactionsImmune Reconstitution Inflammatory Syndrome (IRIS)Potential for off-target immune activationJarisch-Herxheimer-like reactions
06

Interacting drugs

Caspofungin

6 more in the full profile.

07

Biomarkers

1,3-beta-D-glucan (BDG)Galactomannan (GM)Cryptococcal capsular antigen (CrAg)Mannan and anti-mannan antibodies

Beyond the preview

Go deeper on Fungal antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call